Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Safety and Effectiveness of LUCEMYRA in the Treatment of Opioid Withdrawal During an Opioid Taper in Subjects With Chronic Non-Cancer Pain

NCT04070157 is registered in ClinicalTrials.gov with USWM, LLC (dba US WorldMeds) as lead sponsor.

NCT NCT04070157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04070157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Safety and Effectiveness of LUCEMYRA in the Treatment of Opioid Withdrawal During an Opioid Taper in Subjects With Chronic Non-Cancer Pain
Lead sponsor
USWM, LLC (dba US WorldMeds)
Phase
Phase 2
Overall status
Terminated
Start date
August 2, 2019
Completion date
November 27, 2019
Enrollment
4 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

opioid withdrawal (disorder)